Delivery Order SPE2DB22D2006-SPE2DB23FW1JS
Award Date 7/21/23
Potential Completion Date 7/24/23
Potential Value $273
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $376.07 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30 units of 8-2mg Buprenorphine-Naloxone film. The place of performance is Amerisourcebergen's Conshohocken, Pennsylvania facility. The period of performance is July 10-11, 2023. As the DLA supports military treatment and procurement programs, this contract for opioid addiction treatment medication will likely supply an on-base pharmacy. Amerisourcebergen, a subsidiary of...
- The Defense Logistics Agency awarded a $338 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30 boxes containing 8-2mg films of buprenorphine-naloxone. The place of performance is Amerisourcebergen's Conshohocken, Pennsylvania facility. The order is for a three-day period from September 8-11, 2023 under the DLA's pharmaceuticals contract vehicle. As a top 10 provider of pharmaceuticals and medical supplies to the DOD, Amerisourcebergen will deliver these opioid addiction...
- The Defense Logistics Agency awarded a $205,760 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 30 packages containing 8-2mg films of buprenorphine-naloxone. The place of performance is the prime contractor's facility located in Conshohocken, Pennsylvania. The order is to be completed by July 28, 2023 under the terms set forth. No additional details were provided regarding the solicitation, vehicle, or subcontractors involved. The Defense Logistics...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $678 to Amerisourcebergen Drug Corporation for 30 packages of 8-2mg films of buprenorphine-naloxone. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The period of performance is August 15 through August 16, 2023. As the DLA supports military treatment and procurement programs, this contract for opioid addiction treatment medications was likely issued under the...
- The Defense Logistics Agency Troop Support Medical awarded a $549 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30 boxes containing 8 mg buprenorphine tablets. The place of performance is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 6, 2023 through July 7, 2023. This delivery order was issued against an existing DLA medical supply vehicle and will provide the agency with a one-day supply of an opioid addiction...
- The Defense Logistics Agency awarded a $283,180 delivery order to Amerisourcebergen Drug Corporation for the supply of 4562152872 units of buprenorphine-naloxone sublingual film. The firm fixed price order is for fulfillment from Amerisourcebergen's facility in Conshohocken, Pennsylvania and has a period of performance spanning September 13 through September 14, 2023. As a top supplier of pharmaceuticals to the U.S. Department of Defense, Amerisourcebergen will deliver the opioid addiction...
- The Defense Logistics Agency awarded a delivery order valued at $1,120.19 to AmerisourceBergen Drug Corp for the supply of Buprenorphine-Naloxone 12-3mg film strips (30-count packages) on July 14, 2025, with an ultimate completion date of July 15, 2025. This non-competitive, firm fixed-price delivery order will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's broader Indefinite Delivery...
- The Defense Logistics Agency awarded a $411,440 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the provision of 30 units of buprenorphine-naloxone 8-2mg films. The place of performance is the prime contractor's facility located in Conshohocken, Pennsylvania. The order is valid from June 29, 2023 through June 30, 2023 to supply the opioid addiction treatment medication to support DLA programs. No subcontractors or set aside designations were identified. The award...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at approximately $1,669 to Amerisourcebergen Drug Corporation for the supply of 30 units of 8-2mg films of buprenorphine-naloxone. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a two day period concluding on July 28, 2023. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will serve as the prime contractor on this...
- The Defense Logistics Agency awarded a $156,600 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 30 packages containing 8-2mg films of buprenorphine-naloxone. The place of performance for this single-day contract is the prime contractor's facility located in Conshohocken, Pennsylvania. No additional details were provided regarding the solicitation or overarching contract vehicle. The contract supports Defense Logistics Agency programs and has no set-aside...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB23FW1JSDelivery Order
The Defense Logistics Agency awarded a $272,850 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 30 packages containing 4-1mg films of buprenorphine-naloxone. The place of performance for this single award delivery order is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The order period of performance spans from July 21, 2023 through July 24, 2023. No major subcontractors or set aside designations were identified. This delivery order was issued against an existing DLA pharmaceutical supply vehicle to support treatment programs addressing opioid use disorder, a key priority for the agency.
Generated 12/24/23, 3:47 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $273 | 7/21/23 |